Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development

Immunome, Inc. (NASDAQ:IMNM) is one of the best cancer stocks to invest in now. On February 14, Immunome, Inc. (NASDAQ:IMNM) CEO and Chairman Clay Siegall reiterated heightened focus on building an oncology-focused pipeline centered on cell-surface-targeting agents and small molecules. Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development David Smart/Shutterstock.com The ultimate goal is to develop a targeted oncology platform for small molecules that can overcome resistance and ...